Further Evidence Does Not Support Hydroxychloroquine for Patients with COVID-19

Posted on May 19, 2020 by admin_imw

5/19/20

Hydroxychloroquine

Enable IntenseDebate Comments:

Enable IntenseDebate Comments

The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with pneumonia due to covid-19, finds a study from France published by The BMJ last Thursday.

Click here to cancel reply.

You must be logged in to post a comment.